<?xml version="1.0" encoding="UTF-8"?>
<p id="Par21">There is a risk of immune checkpoint inhibitor-associated pneumonia in patients who receiving immunotherapy. The clinical symptoms of the immune checkpoint inhibitor-associated pneumonia including fever, increased cough and sputum, and increased dyspnea. Chest CT shows ground glass and flake shadows in the lungs, and some patients can simply show ground glass shadows in the lungs [
 <xref ref-type="bibr" rid="CR49">49</xref>]. This also requires multidisciplinary cooperation including oncology, imaging, and infectious diseases, comprehensive analysis and identification, and guidance for subsequent treatment.
</p>
